Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
AQ-13 veelbelovend medicijn tegen resistente ‘Plasmodium falciparum’
sep 2017 | Parasitaire infecties